Literature DB >> 23134890

Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.

Christina C Dahm1, Anders Gorst-Rasmussen, Francesca L Crowe, Nina Roswall, Anne Tjønneland, Dagmar Drogan, Heiner Boeing, Birgit Teucher, Rudolf Kaaks, George Adarakis, Dimosthenes Zylis, Antonia Trichopoulou, Veronika Fedirko, Veronique Chajes, Mazda Jenab, Domenico Palli, Valeria Pala, Rosario Tumino, Fulvio Ricceri, Henk van Kranen, H Bas Bueno-de-Mesquita, Jose R Quirós, María-José Sánchez, Leila Luján-Barroso, Nerea Larrañaga, María-Dolores Chirlaque, Eva Ardanaz, Mattias Johansson, Pär Stattin, Kay-Tee Khaw, Nick Wareham, Petra A Wark, Teresa Norat, Elio Riboli, Tim J Key, Kim Overvad.   

Abstract

BACKGROUND: Fatty acids in blood may be related to the risk of prostate cancer, but epidemiologic evidence is inconsistent. Blood fatty acids are correlated through shared food sources and common endogenous desaturation and elongation pathways. Studies of individual fatty acids cannot take this into account, but pattern analysis can. Treelet transform (TT) is a novel method that uses data correlation structures to derive sparse factors that explain variation.
OBJECTIVE: The objective was to gain further insight in the association between plasma fatty acids and risk of prostate cancer by applying TT to take data correlations into account.
DESIGN: We reanalyzed previously published data from a case-control study of prostate cancer nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. TT was used to derive factors explaining the variation in 26 plasma phospholipid fatty acids of 962 incident prostate cancer cases matched to 1061 controls. Multiple imputation was used to deal with missing data in covariates. ORs of prostate cancer according to factor scores were determined by using multivariable conditional logistic regression.
RESULTS: Four simple factors explained 38% of the variation in plasma fatty acids. A high score on a factor reflecting a long-chain n-3 PUFA pattern was associated with greater risk of prostate cancer (OR for highest compared with lowest quintile: 1.36; 95% CI: 0.99, 1.86; P-trend = 0.041).
CONCLUSION: Pattern analyses using TT groupings of correlated fatty acids indicate that intake or metabolism of long-chain n-3 PUFAs may be relevant to prostate cancer etiology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134890     DOI: 10.3945/ajcn.112.034157

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  15 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study.

Authors:  Meng Yang; Azalea Ayuningtyas; Stacey A Kenfield; Howard D Sesso; Hannia Campos; Jing Ma; Meir J Stampfer; Jorge E Chavarro
Journal:  Cancer Causes Control       Date:  2016-08-03       Impact factor: 2.506

Review 3.  Health Benefits, Food Applications, and Sustainability of Microalgae-Derived N-3 PUFA.

Authors:  Yanjun Liu; Xiang Ren; Chao Fan; Wenzhong Wu; Wei Zhang; Yanwen Wang
Journal:  Foods       Date:  2022-06-25

4.  Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid.

Authors:  Andrea Comba; Luciana L Almada; Ezequiel J Tolosa; Eriko Iguchi; David L Marks; Marianela Vara Messler; Renata Silva; Maite G Fernandez-Barrena; Elisa Enriquez-Hesles; Anne L Vrabel; Bruno Botta; Lucia Di Marcotulio; Volker Ellenrieder; Aldo R Eynard; Maria E Pasqualini; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

5.  Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy.

Authors:  Colette Galet; Kiran Gollapudi; Sevan Stepanian; Joshua B Byrd; Susanne M Henning; Tristan Grogan; David Elashoff; David Heber; Jonathan Said; Pinchas Cohen; William J Aronson
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-29

6.  High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions.

Authors:  Sophie Bernichtein; Natascha Pigat; Thierry Capiod; Florence Boutillon; Virginie Verkarre; Philippe Camparo; Mélanie Viltard; Arnaud Méjean; Stéphane Oudard; Jean-Claude Souberbielle; Gérard Friedlander; Vincent Goffin
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 7.  Prostate cancer and the influence of dietary factors and supplements: a systematic review.

Authors:  Dalvinder Mandair; Roberta Elisa Rossi; Marinos Pericleous; Tara Whyand; Martyn Evan Caplin
Journal:  Nutr Metab (Lond)       Date:  2014-06-16       Impact factor: 4.169

Review 8.  Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review.

Authors:  Monique Aucoin; Kieran Cooley; Christopher Knee; Heidi Fritz; Lynda G Balneaves; Rodney Breau; Dean Fergusson; Becky Skidmore; Raimond Wong; Dugald Seely
Journal:  Integr Cancer Ther       Date:  2016-06-29       Impact factor: 3.279

Review 9.  Effects of omega-3 fatty acids on patients undergoing surgery for gastrointestinal malignancy: a systematic review and meta-analysis.

Authors:  Jing Yu; Lian Liu; Yue Zhang; Jia Wei; Fan Yang
Journal:  BMC Cancer       Date:  2017-04-14       Impact factor: 4.430

10.  Using Genetic Variants to Evaluate the Causal Effect of Plasma Phospholipid Fatty Acids on Breast Cancer and Prostate Cancer: A Mendelian Randomization Study.

Authors:  Ze Yang; Jingjia Li; Yandi Sun; Zihao Qu; Yindan Lin; Lihong Zhang; Qian He; Xueyao Jia; Mashaal Ahmad; Xueyun Zhang; Yan Luo
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.